Neurocrine Biosciences NBIX
NASDAQ NBIX
$143.18 +2.47 (+1.76%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neurocrine Biosciences (NBIX) Depreciation and Depletion (2019 - 2026)

Updated

Neurocrine Biosciences (NBIX) reported Depreciation and Depletion of $8.4 million for Q2 2026, up 33.3% from $6.3 million a year earlier and up 16.7% from the prior quarter.

Analysis

Neurocrine Biosciences (NBIX) Depreciation and Depletion (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Neurocrine Biosciences' Depreciation and Depletion came in at $28.7 million, up 16.2% year-over-year; for FY2025, it was $26 million, up 10.6% from FY2024.

  • Depreciation and Depletion has increased for 12 consecutive years, with a five-year compound annual growth rate of 24.8% (FY2020 to FY2025).
  • By year, Depreciation and Depletion came in at $23.5 million in FY2024 (+32.0%), $17.8 million in FY2023 (+17.9%), $15.1 million in FY2022 (+38.5%) and $10.9 million in FY2021 (+26.7%).
  • The Q2 2026 figure ranks as the highest quarterly Depreciation and Depletion in data going back to Q1 2019.
  • Year over year, Depreciation and Depletion has now increased in each of the last four quarters, with growth averaging 17.1% over the last eight quarters.
  • The high point for year-over-year Depreciation and Depletion in five years was Q2 2024 (growth of 52.4%); the low point was Q2 2025 (a decline of 1.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $7.2 million (Q1 2026), $6.4 million (Q4 2025) and $6.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Neurocrine Biosciences 14.55 Bn 10.25 Bn 935.80 Mn 8.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.40 Mn
Mar 31, 2026 7.20 Mn
Dec 31, 2025 6.40 Mn
Sep 30, 2025 6.70 Mn
Jun 30, 2025 6.30 Mn
Mar 31, 2025 6.60 Mn
Dec 31, 2024 6.20 Mn
Sep 30, 2024 5.60 Mn
Jun 30, 2024 6.40 Mn
Mar 31, 2024 5.30 Mn
Dec 31, 2023 4.90 Mn
Sep 30, 2023 4.60 Mn
Jun 30, 2023 4.20 Mn
Mar 31, 2023 4.10 Mn
Dec 31, 2022 3.90 Mn
Sep 30, 2022 4.00 Mn
Jun 30, 2022 3.90 Mn
Mar 31, 2022 3.30 Mn
Dec 31, 2021 3.00 Mn
Sep 30, 2021 2.80 Mn
API Access

Neurocrine Biosciences Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=NBIX&period=max&api_key=YOUR_API_KEY